Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1056 results for "pharma trading company"

Ajanta Pharma Q2 net up 26% at Rs 130.66 crore

Shares of the company were trading at Rs 1,967.45 a scrip in afternoon trade on BSE, down 1.33% from previous close Press Trust of India | New Delhi October 26, 2016 Last Updated at 16:22 IST Business Standard, 1 month ago
Alembic Pharma receives EIR report from USFDA Business Standard, 2 months ago

60 images for pharma trading company

Ticker Report, 3 days ago
Zolmax News, 1 week ago
American Banking News, 1 week ago
WKRB News, 1 week ago
American Banking News, 1 week ago
American Banking News, 1 week ago
WKRB News, 2 weeks ago
WKRB News, 3 weeks ago
American Banking News, 4 weeks ago
Ticker Report, 1 month ago

Marksans Pharma jumps 12% post USFDA nod for anti-allergy drug

Shares of Marksans Pharma surged over 12 per cent in early trade today after the company received approval from the USFDA for loratadine liquid filled capsules, used for treatment of allergies, in the American market. The stock jumped 12.53 per ...
 Business Standard2 months ago Marksans Pharma gets USFDA clearance for allergy drug  DNA2 months ago

Zydus Cadila goes for collaboration for anti-malaria drug

The pharma company's shares were trading in the green on the announcement.
 DNA2 months ago

Veritas begins trading on Frankfurt Exchange's Xetra

Dr. Lui Franciosi reports VERITAS RECEIVES LISTING ON THE XETRA (FRANKFURT, GERMANY) TRADING VENUE Veritas Pharma Inc.'s common shares, as of Dec. 7, 2016, are accepted for continuous trading on the electronic trading platform Xetra on the ...
 Stockwatch1 day ago Veritas Receives Listing on the XETRA(tm) (Frankfurt, Germany) Trading Venue  4 Traders1 day ago Big Pharma is Bullish on Electroceuticals Should You?  Digital Journal1 day ago VERS PHAR : Veritas Receives Listing on the Xetra(R) (Frankfurt, Germany) Trading Venue  4 Traders1 day ago

Vanda Pharma settles Fanapt patent litigation with Apotex

Vanda Pharmaceuticals Inc. (Vanda), a specialty pharmaceutical company, has entered into a License Agreement (the License Agreement) with Apotex Inc. and Apotex Corp. (collectively, Apotex) to resolve Vanda's patent litigation against Apotex ...
 PharmaBiz2 hours ago
News Is Money

Horizon Pharma Shares Plunge on Failed Late-Stage Study

Horizon Pharma PLC shares slid 20% in premarket trading after a late-stage study for a genetic disease treatment broadly failed testing. The Irish biopharmaceutical company said phase 3 of its study for a treatment for Friedreich's ataxia, a ...
 Morningstar.com20 hours ago Stone Energy Corporation (NYSE:SGY) & Horizon Pharma PLC (NASDAQ:HZNP) Stocks in the Spotlight  News Is Money3 days ago

HedgePath Pharmaceuticals Announces Uplisting to OTCQX

TAMPA, Fla., Dec. 8, 2016 /PRNewswire/ -- HedgePath Pharmaceuticals, Inc. (HPPI), a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, announced today that ...
 Yahoo! Finance22 hours ago HedgePath Pharmaceuticals, Inc. (HPPI: OTCQX U.S.) | HedgePath Pharmaceuticals Announces Uplisting to OTCQX  OTC Markets22 hours ago

Sun Pharma share up 2%, no repeat USFDA observation for Halol Unit

Sun Pharmaceuticals Industries Ltd is currently trading up 2.01%. Post the conclusion of the inspection, the USFDA issued a Form-483, citing nine inspectional observations. None of those observations were characterized by the USFDA as repeat ...
 India Infoline1 day ago SUN PHARMACEUTICAL INDUSTRIES : Pharma share up 2%, no repeat USFDA observation for Halol Unit  4 Traders18 hours ago

Sun Pharma Advanced Research Company (₹317.1)

: The stock of Sun Pharma Advanced Research Company (SPARC) fell 3.6 per cent on Wednesday on encountering a key resistance at around ₹333. Since registering an all-time high at ₹593 in March 2015, the stock has been trending down. In ...
 Hindu Business Line1 day ago

Laurus Labs Launches IPO At Premium Valuations

Lauras Labs Ltd. will be the third company to hit the primary market since demonetisation. The pharmaceutical company is looking to raise around Rs 1,330 crore through an initial public offering at a price band of Rs 426-428 per equity share. The ...
 Bloomberg-Quint3 days ago Laurus Labs: Costly prescription  Smart Investor3 days ago India: Ahead of IPO, Laurus Labs sells shares for $58m to 25 anchor investors  DealStreetAsia3 days ago Laurus Labs IPO subscribed 28% on Day 1  Livemint.com2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less